Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis
about
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid ArthritisPredominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritisTransgenic mouse models of rheumatoid arthritis.Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.DRB1*0402 may influence arthritis by promoting naive CD4+ T-cell differentiation in to regulatory T cells.Comparative analysis of collagen type II-specific immune responses during development of collagen-induced arthritis in two B10 mouse strains.Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis.Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis.Altered influenza virus haemagglutinin (HA)-derived peptide is potent therapy for CIA by inducing Th1 to Th2 shift.Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.Superior molecularly altered influenza virus hemagglutinin peptide 308-317 inhibits collagen-induced arthritis by inducing CD4+ Treg cell expansion.Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
P2860
Q28395318-E67B943B-5EB7-45DB-86CD-F30ABD8F710DQ31089923-1977494D-E8B3-4AD4-91F7-7E8C12D39974Q33713326-EC0184F2-AD39-42AB-BDA6-33517E236759Q33713407-A34178C8-7027-4831-B71A-3482D85DE0BFQ34516919-535BAB68-3CAA-4863-8E9A-86FFD92C6BF6Q36907623-CAD8CD54-1475-4C4B-930B-9E8FF4AEA4F2Q37382486-6366C05F-C160-41C8-91D0-C80FF51433DFQ37598701-93AC331F-C10C-42F5-ACAF-09DB718E1194Q37728230-1B057B2D-C1D7-4D08-A653-90C7579DF547Q38569872-AAE0756F-28CA-41E4-8695-8F6C9C5A6F7EQ40443201-19AAD5C8-9406-4CA7-A843-ACB02D606FB8Q45360543-4EC87D75-6657-4B65-8F59-056B0EE720BCQ45420244-A77F2291-8F1B-4611-927D-F46F9F0F8B11
P2860
Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@ast
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@en
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@nl
type
label
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@ast
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@en
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@nl
prefLabel
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@ast
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@en
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@nl
P2093
P356
P1433
P1476
Human collagen II peptide 256- ...... bility to rheumatoid arthritis
@en
P2093
C de Préval
F E L'Faqihi
N C Lambert
P Loubet-Lescoulié
P2888
P356
10.1007/S002510050461
P407
P577
1999-01-01T00:00:00Z
P6179
1009012500